Companies / Amerigo Scientific / "Amylin, human"
Amerigo Scientific

"Amylin, human" | Amerigo Scientific

Amylin, human

Diabetes-associated Peptide (DAP) Amide, human

MW: 3904.1

H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2

(Cys2-7, cyclic)

Diabetes-associated peptide (DAP), the C-terminal deaminated form of amylin, was originally isolated from amyloid rich pancreatic tissue of diabetic patients. It also occurs in normal adult islet cells. Amylin inhibits basal and insulin stimulated glucose uptake. Both DAP and amylin are active in vivo and in vitro.

Cooper, G.J.S. et al. (1987) Proc. Soc. Natl. Acad. Sci. USA 84, 8628;

Westermark, P. et al. (1987) Proc. Soc. Natl. Acad. Sci. 84, 3881.

500µg

1mg

Reviews


No reviews yet

ABOUT THE COMPANY

Amerigo Scientific is a distribution company focused on providing critical products and services to the biomedical and life science research communities. Although a new company, Amerigo Scientific's founder has had more than 20 years of rich experience in the biomedical and biochemical fields, and has established close contacts with key personnel in...
READ MORE
  • See More